PTSD Trial, Recruiting NCT06341413 Sponsor: University of Wisconsin, Madison Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT06341413
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 15 and 18 years old (inclusive)
  • You are able to lie still on your back for up to 1 hour
  • You are not pregnant and do not become pregnant during the study
  • You agree to tell the research team about any urgent medical situations within 48 hours of them happening
  • You agree not to join any other interventional clinical trials while this study is ongoing
  • You are willing to follow all study procedures
  • You agree to have your study visits recorded by video and/or audio (recordings are deleted within one month of the visit)
  • A parent or guardian is willing to take part and provide consent on your behalf
  • You speak and read English fluently or as your main language

If you are in the PTSD or trauma-exposed group, you also need to:

  • Have experienced at least one traumatic event (as defined by medical guidelines), such as physical or sexual abuse, witnessing violence, a serious accident, a natural disaster, or the death of a close family member
  • If joining as someone with PTSD: currently meet the full criteria for severe PTSD, confirmed through a clinical interview

Who may not be able to join:

  • Your parent/guardian or you are unable or unwilling to give proper consent
  • The research team believes you are likely to be exposed to further serious trauma, do not have enough social support, or do not have a stable living situation during the study
  • The lead researcher feels, based on screening, that the study would not be suitable for you for any reason
  • You have taken part in a clinical study involving an experimental drug in the last 30 days
  • You have a medical reason why you cannot have an MRI scan (confirm with trial site)
  • You experience claustrophobia (fear of enclosed spaces) or cannot lie still in the MRI scanner, even after practice sessions
  • You are currently considered to be at serious risk of suicide (though a past history of suicide attempts does not automatically exclude you)
  • You are considered a serious risk to others, based on a clinical interview
  • You have been diagnosed with autism spectrum disorder
  • You have an intellectual disability (IQ below 70, based on self-report)
  • You currently have a medical condition that would prevent you from taking part
  • You have had a traumatic brain injury and are still experiencing symptoms such as headaches, vision problems, or difficulty concentrating
  • You have a neurological condition such as seizures, epilepsy, or a brain tumour (note: Tourette's disorder does not exclude you if you are in the PTSD or trauma-exposed group)
  • You are currently using medications or substances, including alcohol, in a way that may affect your sleep
  • There is a possibility you may be pregnant

Additional exclusions if you are in the typically developing (no trauma) group:

  • You have a current or past mental health diagnosis (with the exception of a past specific phobia)
  • You currently have a diagnosed sleep disorder (based on self-report)
  • You have any history of traumatic experiences as defined by medical guidelines, including exposure to domestic violence, neglect, or emotional abuse

Additional exclusions if you are in the PTSD group:

  • You have a current diagnosis or history of a psychotic disorder, bipolar disorder, or autism spectrum disorder (confirmed by clinical interview)

Additional exclusions if you are in the trauma-exposed (but not PTSD) group:

  • You currently have PTSD, or have a current diagnosis or history of a psychotic disorder, bipolar disorder, or autism spectrum disorder (confirmed by clinical interview)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stephanie Jones, MD, PhD, University of Wisconsin, Madison

Phone: 303-296-2116

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 July 2024
Est. completion
1 October 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Emotional Regulation - arousal; Change in Emotional Regulation - recall; Change in Slow-wave Activity (SWA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov